Literature DB >> 28662283

Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab.

D Tomsitz1, R Hein1, T Biedermann1, J Kohlmeyer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28662283     DOI： 10.1111/jdv.14450

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

Review 1.  Immune Checkpoint Inhibitors in Melanoma and HIV Infection.

Authors:  Antonio Marra; Giosuè Scognamiglio; Ilaria Peluso; Gerardo Botti; Celeste Fusciello; Amelia Filippelli; Paolo A Ascierto; Stefano Pepe; Francesco Sabbatino
Journal:  Open AIDS J       Date:  2017-11-14

2.  Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection.

Authors:  Muhammad Husnain; Wungki Park; Juan Carlos Ramos; Thomas E Johnson; Joseph Chan; Arvind Dasari; Raja Mudad; Peter J Hosein
Journal:  J Immunother Cancer       Date:  2018-07-09       Impact factor: 13.751

3.  Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART.

Authors:  John K Bui; Joshua C Cyktor; Elizabeth Fyne; Shalyn Campellone; Stephen W Mason; John W Mellors
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.